Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 35,000 NVCT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Nuvectis Pharma, Inc. (NVCT) | Grant/Award | 35,000 | n/a |
| Jun 12, 2025 | Nuvectis Pharma, Inc. (NVCT) | Grant/Award | 30,000 | n/a |
| Jun 28, 2024 | Checkpoint Therapeutics, Inc. (CKPT) | Sale | 24,610 | $50.5K |
| Jun 13, 2024 | Nuvectis Pharma, Inc. (NVCT) | Grant/Award | 30,000 | n/a |
| May 24, 2024 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/Award | 1,660,000 | n/a |
| Mar 1, 2024 | Checkpoint Therapeutics, Inc. (CKPT) | Sale | 5,894 | $12.1K |
| Feb 2, 2024 | Checkpoint Therapeutics, Inc. (CKPT) | Sale | 11,900 | $23.9K |
| Jun 20, 2023 | Nuvectis Pharma, Inc. (NVCT) | Grant/Award | 18,000 | n/a |
| Apr 5, 2022 | Nuvectis Pharma, Inc. (NVCT) | Grant/Award | 15,000 | n/a |